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Superantigens stimulate T-lymphocyte proliferation and cytokine production, but the effects of superantigen
exposure on cell function within a complex, highly regulated immune response remain to be determined. In this
study, we demonstrate that superantigen exposure significantly alters the murine host response to bacterial
antigens in an in vitro coculture system. Two days after exposure to the superantigen staphylococcal entero-
toxin B, splenocytes cultured with Streptococcus mutans produced significantly greater amounts of gamma
interferon (IFN-g) and interleukin-12 than did sham-injected controls. The majority of IFN-g production
appeared to be CD81 T-cell derived since depletion of this cell type dramatically reduced the levels of IFN-g.
To study host cell damage that may occur following superantigen exposure, we analyzed cytotoxicity to
“bystander” fibroblast cells cultured with splenocytes in the presence of bacterial antigens. Prior host exposure
to staphylococcal enterotoxin B significantly enhanced fibroblast cytotoxicity in the presence of bacteria.
Neutralization of IFN-g decreased the amount of cytotoxicity observed. However, a greater reduction was
evident when splenocyte-bacterium cocultures were separated from the bystander cell monolayer via a perme-
able membrane support. Increased cytotoxicity appears to be primarily dependent upon cell-cell contact.
Collectively, these data indicate that overproduction of inflammatory cytokines may alter the activity of
cytotoxic immune cells. Superantigen exposure exacerbates cytokine production and lytic cell activity when
immune cells encounter bacteria in vitro and comparable activities could possibly occur in vivo.
Superantigen proteins cause excessive stimulation of host
immune cells and lead to illness and disease in mammals,
including humans (14, 23, 33, 34). Major superantigens are
secreted bacterial toxins such as staphylococcal enterotoxins
and toxic shock syndrome toxin, although additional ones have
been associated with streptococci, pseudomonads, clostridia,
and mycoplasmas (5, 7, 9, 22, 40). Other reported superanti-
gens are virally encoded proteins such as the minor lympho-
cyte-stimulating factor of the mouse mammary tumor virus (8),
the Epstein-Barr virus-associated superantigen (21), and pos-
sibly the human immunodeficiency virus Nef protein (36, 37,
41).
Superantigens such as staphylococcal enterotoxin B (SEB)
differ from conventional antigens in that they do not require
processing and presentation with major histocompatibility
complex (MHC) on the surface of antigen-presenting cells
(APC). Superantigens interact with nonpolymorphic regions of
the MHC molecule and specific Vb regions of the T-cell re-
ceptor heterodimer outside of the peptide binding groove (13,
42). This interaction stimulates cellular proliferation and cyto-
kine production, e.g., gamma interferon (IFN-g), by Vb-reac-
tive T cells independent of T-cell receptor specificity for con-
ventional antigen (24). Ultimately, many of these T cells
become anergic or are deleted (29). However, some of these
cells do not remain unresponsive in vivo and appear to be fully
functional in vitro when APC present a high concentration of
superantigen along with appropriate costimulation (17, 18). In
the present study, we address how superantigen-stimulated
immune cells respond to bacterial antigenic stimulation in
vitro.
We have developed a novel coculture system to address how
superantigen exposure alters the host response to native, con-
ventional bacterial antigen (30). In this system, murine spleno-
cytes isolated from BALB/c mice that were previously injected
with SEB or saline are cocultured with viable bacterial cells in
the presence of spectinomycin, a bacteriostatic antibiotic. The
splenocyte pool contains a mixture of immune cell types (e.g.,
T and B lymphocytes, macrophages, and natural killer cells)
and serves as a model for in vivo immune responses. The
bacteria do not multiply in the coculture system but presum-
ably retain their native surface antigens. In addition, spleno-
cyte viability is not affected by the presence of the bacteria,
allowing the study of bacterium-host cell interaction and re-
sponses (11).
In the present studies, we analyzed IFN-g and interleukin-12
(IL-12) secretion by splenocytes isolated from SEB-pretreated
mice that were cultured with gram-positive bacteria. IFN-g-
secreting lymphocytes were identified by flow cytometry utiliz-
ing intracellular cytokine staining and cell surface phenotype
markers and were confirmed by depletion of this cell type. We
compared splenocytes isolated from SEB and phosphate-buff-
ered saline (PBS)-pretreated mice for cytotoxicity and studied
the role of cytokine and cell contact in these effects. This is the
first study to demonstrate how prior in vivo exposure to supe-
rantigen augments cytokine production and cytotoxicity in re-
sponse to viable bacterial cells in vitro.
MATERIALS AND METHODS
Animals. Eight- to ten-week-old female BALB/c mice (Harlan Sprague-Daw-
ley, Indianapolis, Ind.) were used in the study. Mice were injected intraperito-
neally with 50 mg of SEB (Toxin Technology, Sarasota, Fla.) in 0.2 ml of PBS (pH
7.2) or with 0.2 ml of PBS alone. Splenocyte pools of at least three mice were
used for each experiment.
Bacteria and culture conditions. Streptococcus mutans, which colonizes the
oral cavity, was obtained from the American Type Culture Collection (ATCC).
In previous coculture studies, S. mutans generated the greatest IFN-g response.
Bacteria grown aerobically at 37°C overnight in brain heart infusion broth (BHI
broth; Difco, Detroit, Mich.) were diluted 1:10 in BHI broth and grown to
mid-log phase (108 cells ml21). Cell density was determined by monitoring the
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optical density at 600 nm (OD600) with a nephelometer flask and spectropho-
tometer. The cells were centrifuged at 750 3 g (Sorvall GLC-1), washed once in
100 mM sodium phosphate buffer (pH 7.2), and resuspended in RPMI 1640
medium supplemented with 10% bovine calf serum, 2 mM L-glutamine, and 25
mM HEPES to a cell density of about 108 cells ml21.
Cell cocultures. Cell cocultures were as previously described (30). Briefly, at 2
or 4 days postinjection the mice were euthanized by cervical dislocation. Spleens
were aseptically removed, macerated between sterile frosted-end microscope
slides, and washed once in RPMI 1640 medium supplemented with 5% calf
serum and 60 mg of spectinomycin ml21. After erythrocyte lysis, the splenocyte
numbers were determined with a Coulter Counter (Coulter, Hialeah, Fla.), and
3.75 3 106 splenocytes were added to Falcon 24-well tissue culture plates con-
taining 106 bacteria and supplemented RPMI 1640 medium. The final volume of
the coculture was 0.5 ml. Cocultures were incubated at 37°C in a 5% CO2
atmosphere for up to 24 h before the sampling.
IFN-g and IL-12 detection. IFN-g and IL-12 protein levels were quantitated in
culture supernatants by sandwich enzyme-linked immunosorbent assay (ELISA)
using cytokine antibody pairs according to the manufacturer’s recommendations
(PharMingen, Inc., San Diego, Calif.). To detect IFN-g, purified rat anti-mouse
IFN-g monoclonal antibody (clone R4-6A2) was used as a capture antibody at an
optimal concentration of 2 mg ml21. Biotinylated rat anti-mouse IFN-g mono-
clonal antibody (clone XMG1.2) was used as the detection antibody at an
optimal concentration of 1 mg ml21. Recombinant mouse IFN-g (Biosource
International, Camarillo, Calif.) was used for the standard curve determinations.
To detect IL-12, purified rat anti-mouse IL-12 (p40/p70, clone C15.6) was used
as the capture antibody at an optimal concentration of 4 mg ml21. Biotinylated
rat anti-mouse IL-12 monoclonal antibody (clone C17.8) was used for ELISA
detection at an optimal concentration of 2 mg ml21. Recombinant mouse IL-12
(PharMingen) was used for the standard curve determinations. Plates were
developed with avidin-peroxidase working conjugate (diluted 1:300) and the 2,29-
azinobis(3-ethylbenzthiazoline sulfonate) (ABTS) substrate (Sigma, St. Louis,
Mo.). A405 was determined by using a Vmax ELISA microtiter plate reader (Mo-
lecular Devices Corp., Palo Alto, Calif.).
Monoclonal antibodies. Monoclonal antibodies for CD90 (Thy-1.2), CD4
(L3T4), CD8a (Ly-2), Vb 8.1, 8.2, and CD32/CD16 (FcgII/III) were purchased
from PharMingen and were used in single and dual immunofluorescence staining
for flow cytometry. Biotin-labeled anti-mouse CD8a (Ly-2) was purchased from
Caltag Laboratories (Burlingame, Calif.) and used for immunomagnetic deple-
tion experiments. Intracellular cytokine staining was performed with rat anti-
mouse IFN-g (clone XMG1.2) purchased from Caltag Laboratories; this anti-
body gave optimum results. When applicable, isotype-matched controls were
purchased from the same manufacturer. IFN-g was neutralized with a monoclo-
nal rat anti-mouse IFN-g (clone XMG1.2; Caltag).
Flow cytometry. All samples were prepared for flow cytometric analysis as
previously described (30). Samples were analyzed with a Becton Dickinson (San
Jose, Calif.) FACScan, and the data were acquired by setting a live gate on the
mononuclear cell fraction as determined by forward-angle and side-scatter char-
acteristics. Data analysis was performed by using the LYSYS II computer pro-
gram (Becton Dickinson).
Labeling of intracellular cytokines. Intracellular IFN-g was detected as pre-
viously described with phycoerythrin-labeled rat anti-mouse IFN-g (30). Monen-
sin was added to all cultures 6 hours prior to cell harvest to inhibit protein
transport, thereby trapping IFN-g within the cytokine-secreting cell. Without
monensin addition, only about 0.6% of the cells contained detectable intracel-
lular cytokine. Isotype-matched, ligand-blocking, and permeability controls were
included to verify the specificity and location of IFN-g labeling. Samples were
analyzed with a Becton Dickinson FACScan. Data were acquired by setting a live
gate on the T-lymphocyte population, which was approximately 75% Thy-1.21 as
determined by Thy-1.2 fluorescence.
Immunomagnetic depletion. Biotin-conjugated rat anti-mouse CD8a was
bound to streptavidin-labeled M280 magnetic beads at a concentration of 7.5 mg
mg21 of beads as described by the supplier (Dynal, Inc., Lake Success, N.Y.). A
10:1 bead-to-target ratio was used to remove Ly-21 (CD8a) cells from the
splenocyte cell suspensions. The target cell percentage was determined by flow
cytometry. The beads were incubated with target cells for 30 min on a bidirec-
tional rotary platform at 4°C; bead-cell conjugates were harvested with a mag-
netic separator, and the supernatants were collected. The supernatants were
subjected to a second round of depletion. To confirm the efficiency of depletion,
aliquots of depleted cell suspensions were stained with two separate clones of
monoclonal rat anti-mouse Ly-2 antibodies and analyzed by FACScan flow
cytometry. Depleted cell suspensions were ,3% positive for Ly-2 target cells
after two rounds of depletion.
Cytotoxicity assays. A cytotoxicity detection kit (Boehringer Mannheim, In-
dianapolis, Ind.) was used to quantitate cell lysis. Target BALB/c 10CrMCA
A.2R.1 fibroblast cells were obtained from the ATCC and maintained in RPMI
1640 medium supplemented with 10% bovine calf serum, 25 mM HEPES, 2 mM
L-glutamine, and 4.5 g of D-glucose per liter. Splenocyte cell populations were
isolated from PBS- or SEB-pretreated mice and used as the effector cell popu-
lation in the assay. Effector/target cell ratios were optimized for each experiment
and cells were cultured with or without bacteria in Corning 96-well tissue culture
plates. All cells were suspended in RPMI 1640 without phenol red supplemented
with 5% bovine calf serum, 25 mM HEPES, 2 mM L-glutamine, and 60 mg of
spectinomycin ml21. After 18 or 24 h of incubation at 37°C and 3% CO2, the
supernatants were collected and analyzed for the relative release of the
cytosolic enzyme lactate dehydrogenase (LDH) according to manufacturer’s
recommendations. A490 values were obtained by using a 96-well plate reader
(Molecular Devices Corp.). The relative LDH release value for each well was
calculated as follows, where OD is the OD490: [(ODtarget 1 effector 1 bacteria 2
ODeffector 1 bacteria 2 ODtarget 1 bacteria)/(ODtarget(max) 1 bacteria 2 ODtarget 1 bacteria)]
3 100%.
Transwell inserts (Corning Costar Corp., Cambridge, Mass.) and Corning
24-well tissue culture plates were used in the target and effector cell separation
experiments.
Statistical analysis. The data were analyzed by Student’s t test by using Sig-
maStat statistical analysis software (Jandel Scientific, San Rafael, Calif.).
RESULTS
IFN-g production increases in 2-day SEB-pretreated
splenocyte-bacterium cocultures. Two days after SEB or PBS
pretreatment, splenocytes from SEB-pretreated mice cocul-
tured with S. mutans produced significantly (P # 0.001) greater
amounts of IFN-g than PBS-pretreated splenocytes cultured
with S. mutans (Fig. 1A, left panel). Splenocyte cultures with-
out bacteria did not produce elevated IFN-g levels, indicating
that cytokine production occurred in response to bacterial an-
tigens (data not shown). The low IFN-g levels secreted in
PBS-pretreated cocultures indicated that the bacteria do not
possess inherent strong superantigen activity like the SEB
toxin. Splenocytes isolated 4 days after SEB pretreatment gen-
erated lower quantities of IFN-g than did splenocytes isolated
2 days after SEB injection. Despite the lower level of IFN-g
production, splenocytes isolated 4 days after SEB treatment
still yielded a significantly higher IFN-g level (P # 0.001) in the
cocultures than did splenocytes isolated 4 days after PBS pre-
FIG. 1. IFN-g production by SEB- or PBS-pretreated splenocytes after a
24-h coculturing with bacteria. (A) IFN-g produced by spleen cells isolated 2
days or 4 days after SEB or PBS treatment and cocultured with S. mutans. (B)
IFN-g produced by spleen cells isolated 2 days after SEB treatment and cocul-
tured with titrated amounts of viable or heat-killed S. mutans. Each bar repre-
sents the mean value of three separate experiments (three mouse spleen pools
per experiment) 6 the standard error of the mean (SEM).
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treatment (Fig. 1A, right panel). Thus, SEB activation of T
cells may account for the hyperresponsiveness to bacterial an-
tigens observed 2 days after superantigen exposure, but that
response was diminished at 4 days after SEB exposure.
To determine if the levels of cytokine secreted were depen-
dent on the bacterial load in the culture system, splenocytes
isolated 2 days after SEB treatment were cultured with titrated
amounts of S. mutans. In the standard coculture, 106 bacteria
were mixed with 3.75 3 106 splenocytes, yielding a bacterium/
splenocyte ratio of 1:3.75. IFN-g production under these con-
ditions is shown in Fig. 1B (left panel, leftmost bar). As input
bacteria decreased, IFN-g levels also decreased; the addition
of 104 viable bacteria to splenocyte cultures, i.e., a 1:375 ratio
of bacteria to splenocyte cells, was needed to produce signifi-
cant amounts of IFN-g (P # 0.003; Figure 1B, left panel).
Fewer than 103 bacteria did not stimulate cytokine production.
The response to heat-killed bacteria was substantially lower
(Fig. 1B, right panel). Greater levels of heat-killed bacteria
(106) were needed to generate a significant (P # 0.001) IFN-g
response, and even then the cytokine level produced was lower
than that observed with viable bacteria. These findings taken
together indicate that native bacterial antigens are important
for generating the high cytokine response, and the level of the
response is related to bacterial load.
CD81 T cells are responsible for the bulk of IFN-g pro-
duction in cocultures. Using in vivo depletion of natural
killer (NK) cells with anti-asialo ganglio-n-tetraosylceramide
(AAGM1), we have previously shown that about 25% of the
IFN-g in the coculture system is produced by NK cells but that
the majority of IFN-g is generated by T cells (30). To distin-
guish which T-cell type contributed the majority of IFN-g, we
examined intracellular levels of the cytokine. Splenocytes iso-
lated 2 days after SEB treatment were cocultured with S. mu-
tans and analyzed for intracellular IFN-g over a period of 6 to
20 h. The percentage of cells containing intracellular IFN-g
increased at 14 h and peaked at 20 h in both Ly-21 (CD8) and
L3T41 (CD4) T-cell populations (data not shown). Figure 2A
shows that about 84% of the IFN-g-containing cells labeled for
the Ly-2 surface antigen, whereas only about 23% stained for
the L3T4 antigen (Fig. 2B). Preincubation of permeabilized
Ly-21 stained cells with unlabeled rat anti-IFN-g prior to phy-
coerythrin-conjugated rat anti-IFN-g staining limited the spe-
cific labeling of IFN-g to 0.4% (Fig. 2C), a level similar to the
autofluorescence levels. The absence of a permeabilizing
agent, saponin, reduced IFN-g labeling to 0.2% (Fig. 2D),
confirming intracellular staining. Approximately four times
more CD81 T cells stained for intracellular IFN-g than did the
CD41 cells, indicating that CD81 cells were responsible for
more IFN-g production.
Although we did not directly detect whether the CD41 and
CD81 T cells that stained for IFN-g were also Vb81, indirect
data from other flow cytometry experiments gave insight into
the activity of different Vb-specific T cells (Table 1). When the
splenocytes were isolated from the mouse 2 days after SEB
treatment, approximately 6.8% of the T cells were CD81
Vb81 and 10.2% of the cells were CD41 Vb81. After 24 h in
coculture with S. mutans, the percentages of CD81 Vb81 and
CD41 Vb81 T cells both declined to about 4.7%, showing that
the Vb81 population was being depleted over time. When we
compared the percentage of CD81 T cells containing intracel-
lular IFN-g (8.3%) to the CD81 Vb81 T cells in the popula-
tion (4.7%), it was clear that CD81 T cells with different Vb
specificities must be contributing to the IFN-g production in
the coculture. In contrast, although 4.7% of the CD41 cells
were Vb81, the percentage of IFN-g1 CD41 cells was only
about 2.1%, showing that at most half of the CD41 Vb81 T
cells were generating IFN-g.
CD81 cell depletion decreases IFN-g levels. To confirm the
CD81 T-cell contribution to IFN-g production, we removed
these cells from the splenocyte pool prior to coculture. Spleno-
cytes isolated 2 days after SEB treatment were depleted of
Ly-21 cells prior to culturing with S. mutans for 16, 20, and
24 h. In a scatter plot of a nondepleted population gated to
contain approximately 75% of the T cells, 33.8% of the cells
were Ly-21 (data not shown). After two rounds of depletion,
Ly-21 cells decreased to 3.0% of the T-cell population (Fig.
3A, gray histogram) compared to the nondepleted population
FIG. 2. Intracellular labeling of IFN-g in splenocytes isolated 2 days after
SEB treatment and cocultured for 20 h with S. mutans. Splenocytes were stained
for CD81 T cells (A) or CD41 T cells (B) and IFN-g. Preincubation of the fixed
and permeabilized cells with excess unconjugated anti-mouse IFN-g antibody
specifically blocks (BL) cytokine labeling (C), whereas the absence of permeabi-
lization buffer (PC) controls for extracellular cytokine labeling (D). The graphs
represent dual labeling for cellular phenotype (x axis) and IFN-g (y axis). Data
were acquired by collecting 10,000 events gated for approximately 75% of the
Thy-1.21 splenocyte fraction, and quadrant markers were set based on isotype-
stained controls. The plots are representative of two separate experiments. PE,
phycoerythrin; FITC, fluorescein isothiocyanate.
TABLE 1. Analysis of CD81 and CD41 T cells 2 days after
SEB treatment
Markers detected
% of T-cell populationa at:
0 hb 20 to 24 hc
Ly-21 1 Vb81 6.8 6 0.5 4.7 6 0.1
Ly-21 1 IFN-g1 ND 8.3 6 0.1
L3T41 1 Vb81 10.2 6 0.4 4.7 6 0.1
L3T41 1 IFN-g1 ND 2.1 6 0.2
a Live gate set on T cells; 20,000 events were recorded. ND, not done.
b Ly-2 (CD81), L3T4 (CD41), and Vb8 markers were measured on splenocyte
cells immediately after isolation from mice pretreated with SEB 2 days before.
c Ly-2 (CD81), L3T4 (CD41), and IFN-g were measured for splenocytes from
SEB-pretreated mice after 20 to 24 h of coculture with 106 S. mutans.
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(Fig. 3A, overlay) and remained at ,4% after 20 h of coculture
with bacteria (data not shown). After 16, 20, and 24 h of
coculturing, supernatants were collected and analyzed for
IFN-g concentrations. Removal of Ly-21 cells, which repre-
sented about 84% of the T cells staining intracellularly for
IFN-g, resulted in an approximately 85% reduction in IFN-g
levels generated in response to bacteria (Fig. 3B). The remain-
der of the secreted IFN-g in the CD81-depleted cocultures
was probably generated by CD41 T cells and NK cells.
SEB pretreatment primes IL-12 production in response to
bacterial antigens. Since IFN-g production is stimulated by
IL-12 (1), we examined the levels of this cytokine in our co-
culture system. Supernatants from cocultures with splenocytes
2 days after SEB and PBS pretreatment were collected and
analyzed for IL-12 and IFN-g production over a 6- to 24-h
culture period. Figure 4 shows that IL-12 production preceded
IFN-g appearance in the coculture. Only SEB-pretreated
splenocytes cocultured with bacteria resulted in rapid produc-
tion of IL-12, which began at 4 h and peaked at 14 h (6.5 ng
ml21). PBS-pretreated splenocytes only produced about 1 ng
of IL-12 ml21. After IL-12 production, a rapid increase in
IFN-g was observed from 14 to 22 h in cocultures with spleno-
cytes from SEB-pretreated mice. Neutralization of IL-12 in
culture decreases IFN-g levels (data not shown). No IL-12 or
IFN-g was detected in any cultures without bacteria added
(data not shown).
SEB pretreatment augments cytotoxic effects on bystander
cells. To assess host cell damage that may occur following
superantigen exposure, we analyzed cytotoxicity to “bystander”
fibroblast cells when cultured with splenocytes in the presence
of bacterial antigens. PBS- or SEB-pretreated splenocytes were
cultured for 24 h with a BALB/c fibroblast line. SEB-pre-
treated splenocytes in the presence of bacterial cells showed a
statistically significant (P 5 0.028) 35% increase in cytotoxicity
of fibroblasts compared to those levels observed with PBS-
pretreated splenocytes (Fig. 5A). Levels of cytotoxicity were
proportional to the amount of bacteria added per well (data
not shown). Maximal cytotoxicity was attained with 105 bacte-
ria per well. The level of cytotoxicity observed with PBS-pre-
treated splenocytes reflects potential tissue damage as a result
of an inflammatory response to a large bolus of bacteria. Su-
perantigen exposure appears to enhance the cytotoxic effects
on bystander cells in the presence of bacterial antigens.
In order to characterize whether the SEB-enhanced cytotox-
icity is dependent upon IFN-g production, we neutralized
IFN-g activity with titrated amounts of anti-IFN-g and mea-
sured the cytotoxicity after an 18-h culturing of SEB-pre-
treated splenocytes with bacterial cells. As shown in Fig. 5B,
neutralization of IFN-g resulted in a 10% net decrease in
cytotoxicity levels compared to cultures with an isotype control.
IFN-g appears to augment cytotoxic effects on bystander cells.
Since splenocytes from PBS-pretreated mice did not yield ap-
preciable IFN-g in the cocultures, we presumed that this cyto-
kine did not play the same role in causing cytotoxicity in these
cocultures.
Cytotoxicity is dependent upon cell-to-cell contact. To assess
whether cell-cell contact also contributes to the observed cy-
totoxic response, we added a permeable support membrane
(Transwell) to prevent splenocyte and bacterial cell contact
with the fibroblast monolayer. As shown in Fig. 6, blocking the
splenocyte cell contact with the fibroblast monolayer reduced
cytotoxic levels in both PBS- and SEB-pretreated cultures. In
cocultures containing the Transwell inserts, a greater reduction
in the percent cytotoxicity was observed with the superantigen-
activated splenocytes than with the PBS-pretreated splenocytes
(2.2-fold versus 1.8-fold). Although this difference is slight,
these data suggest an important role for direct cell-to-cell con-
tact in mediating cytotoxicity in the coculture system; however,
in cultures containing SEB-pretreated splenocytes, a slightly
higher amount of cytotoxicity seems to be dependent on these
cellular interactions.
FIG. 4. Time course of IL-12 and IFN-g production. Supernatants were
collected from SEB- or PBS-pretreated splenocyte cocultures after 6 to 22 h and
analyzed for IL-12 and IFN-g production. Each datum point represents the mean
of two separate experiments 6 the SEM.
FIG. 3. CD81 T-cell depletion and IFN-g production. (A) A representative
histogram shows CD81 T-cell labeling prior to (black overlay) and after (gray
histogram) depletion of this cell type from splenocytes isolated 2 days after SEB
treatment. (B) CD81 T-cell-depleted and nondepleted splenocytes were cultured
for 16 to 24 h with S. mutans and analyzed for IFN-g production. Each bar
represents the mean value of three separate experiments 6 the SEM.
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Upon exposure to the superantigen SEB, immune cells, es-
pecially T lymphocytes, undergo significant functional alter-
ations. The response mechanisms of superantigen-exposed T
cells to conventional and self antigens is not clearly estab-
lished; however, this response involves cytokine production,
e.g., IL-2, IFN-g, and tumor necrosis factor alpha (TNF-a)
(34), and/or lytic activity of these cells. Previously, we de-
scribed a novel method for coculturing splenocytes with viable
bacteria (30). The splenocyte system had been used earlier by
Bigley and coworkers as an in vitro model that accurately
reflects in vivo immune responses to viral infection (11). This
system allows the study of complex host-bacterium interactions
and the superantigen-altered host response. In the present
study, we further characterize the in vitro immune response to
bacterial antigens after in vivo exposure to SEB.
Our results indicate that superantigen exposure exacerbates
splenocyte cytokine production in the presence of bacteria. A
significant amount of IFN-g is produced only when bacteria
are cultured with splenocytes from SEB-pretreated mice. This
response is evident 2 days after exposure to the superantigen
and increases with exposure to increasing numbers ($104) of
viable bacteria. This heightened response of SEB-pretreated
cells follows the kinetics of SEB stimulation of T lymphocytes
in vivo. Exposure to SEB results in increased Vb81 prolifera-
tion at 2 days postinjection; by 4 days these cells are unrespon-
sive to further SEB stimulation or have been deleted (25).
In the coculture system, a majority of the IFN-g produced in
response to bacterial antigens is generated by CD81 T cells;
some of these cells must have non-Vb8 specificities. SEB ac-
tivates both CD41 and CD81 cells (19, 32) and can interact
with both class I and class II molecules on APC (2, 16). Pre-
sentation of exogenous antigen does not appear to be limited
to class II presentation since macrophages transfer antigens
from phagosomes into the cytosol and endogenous and exog-
enous antigens can use a final common pathway for class I
presentation (26). It is also possible that the bacteria in the
coculture adhere to eukaryotic cells and are possibly internal-
ized, which might lead to class I presentation of bacterial
antigens. In our coculture system, a possible scenario would
involve SEB activation of CD81 cells in vivo that respond in
vitro to MHC class I molecules complexed with bacterial pep-
tides, resulting in IFN-g production. Alternatively, CD81 T
cells may be primed to produce IFN-g as a result of cytokine-
mediated activation. Recently, Coppola and Blackman (10)
demonstrated that CD81 memory T cells do respond to supe-
rantigen stimulation by proliferating and developing effector
lytic function. In addition, SEB stimulates indirect secondary
activation of non-Vb8 reactive T cells (3).
Superantigen exposure may generate a hyperresponsive
state in which antigen-specific cells respond to conventional
(bacterial) antigen in the coculture system, thereby resulting in
excessive cytokine production, effector function, and bystander
cell activation. While some studies indicate that superantigen
exposure contributes to a loss in memory cell function toward
a conventional antigen (4), others maintain that memory T
cells are tolerant to SEB exposure (27). Also, prior exposure to
SEB does not appear to render cells unresponsive to further
superantigen exposure if appropriate antigen presentation and
FIG. 6. Effect of soluble factors on the cytotoxicity of BALB/c fibroblast cells.
A.2R.1 cells (target) were seeded at a density of 2.0 3 105 cells per well in 24-well
plates and allowed to adhere for 10 h at 37°C and 5% CO2. SEB- and PBS-
pretreated splenocytes (effectors) were added at a concentration of 1.5 3 106
cells per well with or without bacteria at 105 cells per well. Parallel cultures
contained permeable membrane inserts to separate the effector and bacterium
cells from the target cells. After 24 h the LDH levels in the culture supernatants
were determined, and the relative target LDH release was calculated as de-
scribed in Materials and Methods. Each bar represents the mean value for three
separate experiments 6 the SEM.
FIG. 5. Cytotoxicity of BALB/c fibroblast cells and effect of IFN-g neutral-
ization. A.2R.1 fibroblast cells (targets) were seeded at a density of 2.0 3 104
cells per well in 96-well plates and allowed to adhere for 10 h at 37°C and 5%
CO2. SEB- and PBS-pretreated splenocytes (effectors) were added at a concen-
tration of 105 cells per well with or without bacteria at 105 cells per well. (A)
After 24 h the LDH levels in culture supernatants were determined and the
relative target LDH release was calculated as described in Materials and Meth-
ods. (B) A titrated concentration of neutralizing rat anti-mouse IFN-g (0.01 mg
ml21) or isotype control was added to cultures at 0 h. After 18 h the LDH levels
in the culture supernatants were determined as described above. Each bar rep-
resents the mean value for three separate experiments 6 the SEM.
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costimulation are provided (17, 18); these cells maintain the
ability to secrete IFN-g (15).
IFN-g is a major activator of macrophages, leading to the
production of TNF-a, IL-1, and IL-12 (12). It is interesting to
note that IL-12 production in the coculture precedes the dra-
matic increase in IFN-g by 8 to 10 h and also that IL-12 is
required to achieve the higher levels of IFN-g. Since NK cells
contribute to IFN-g in the coculture system (30), it is possible
that early IFN-g synthesis by these cells leads to the stimula-
tion of IL-12 production. Although we do not know if the
response of SEB-pretreated mice to bacteria in vivo would be
the same, the splenocyte culture system has previously been
used to predict the in vivo immune response accurately (11).
APC, such as macrophages and dendritic cells, are the pri-
mary producers of IL-12 in vivo (38). In the coculture system,
we do not presently know which APC is responsible for IL-12
production but we are currently investigating this question.
Our coculture data suggest a regulatory effect of IL-12 in
directing production of the striking levels of IFN-g seen in
SEB-pretreated splenocyte-bacterium cultures, an effect which
resembles a T-helper 1 (Th1) response activated by APC (38).
In vivo, SEB stimulates Th1 cytokine production, which con-
tributes to the shock syndrome occurring upon SEB rechal-
lenge (15). Administration of a neutralizing monoclonal anti-
body against IFN-g before that of SEB counteracts the weight
loss and hypoglycemia associated with SEB treatment (31).
Variations in cytokine secretion stimulated by bacterial infec-
tion may possibly elicit a Th1/Th2 imbalance, favoring domi-
nation of one type of response over the other. Th1 skewing by
SEB observed in vivo may account for IFN-g production by
CD81 T cells in our cocultures.
We examined the potential cytotoxic effects generated by
immune cells from superantigen-exposed mice when the cells
encounter bacteria. SEB restimulation in the presence of co-
stimulus-competent APC can revert anergy into responsive-
ness (18). This shift to a responsive state may depend on CD41
T-cell cytokine release and subsequent stimulation of cytokine-
producing CD81 T cells (20). In addition, lytic effector func-
tion does not appear to be compromised by SEB exposure
(35). Utilizing a coculture system, we examined the cumulative
results of superantigen stimulation of Vb–T-cell-specific and
bystander cell activation on host tissue destruction. SEB is
cleared from the host in a matter of hours, yet the effects on T
cells continue beyond 2 days after the exposure (39). This
indicates that a local exposure to superantigen could result in
systemic effects, particularly at sites of bacterial cell coloniza-
tion. In this work, we have shown that SEB exacerbates the
splenocyte cytotoxicity of compatible fibroblast cells only in the
presence of bacteria. One scenario that would explain the
enhanced cytotoxicity is as follows: upon encountering pre-
sented bacterial antigens, a superantigen-altered T cell would
secrete IFN-g and IL-2, further stimulating T-cell effector
functions and cytokine production and activating macrophages
to produce IL-12, TNF-a, nitric oxide, and oxygen intermedi-
ates (6, 28). The activated macrophage would in turn stimulate
more T cells to respond. This overproduction of cytokines may
contribute to host tissue destruction at the site of bacterial
colonization. In contrast, a typical interaction of T cells and
APC would stimulate cytokine cascades to clear the invading
bacteria, but the additional secretion of regulatory cytokines
would be available to downregulate the response. Although we
have no evidence for downregulatory effects in PBS-pretreated
cocultures, we do not observe the high levels of IFN-g in these
cocultures that are seen in SEB-pretreated cocultures. Neu-
tralization of IFN-g leads to a reduction in observed cytotox-
icity, suggesting an involvement of cytokine-mediated lytic ac-
tivities. Separation of splenocytes and bacteria from fibroblast
cells by way of a porous membrane demonstrates that cell-cell
contact is a key component for these cytotoxic effects. Cyto-
toxicity is observed in the cocultures even with splenocytes
from PBS-pretreated mice, but it should be noted that the
magnitude of the response is greater in the SEB-treated cul-
tures. It is possible that the bacteria actually are tightly asso-
ciated with the fibroblast cells and stimulate a cytotoxic re-
sponse. Overproduction of inflammatory cytokines in these
cultures could enhance the activity of the cytotoxic immune
cells.
It is clear from this study that SEB exposure plays a signif-
icant role in directing an inflammatory response. The height-
ened cytokine levels observed when SEB-pretreated spleno-
cytes were cultured with bacteria favors a proinflammatory
response, one possibly contributing to tissue destruction in
vivo. We do not know if other superantigens would stimulate
the same response; however, since the mechanism of activity
seems to be conserved for different superantigens, similar re-
sults might be expected if other superantigens were used.
These data give insight into how superantigens may contribute
to many inflammatory disease processes.
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